News from atai life sciences A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 23, 2020, 11:00 ET ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round

ATAI Life Sciences ("ATAI" or the "Company"), a global biotech company developing psychedelic and non-psychedelic compounds for various mental health ...


Oct 27, 2020, 08:30 ET ATAI Life Sciences Announces Neuronasal Completes Pilot Study, Receives IND Clearance to Continue into Phase I Trials of mTBI Therapeutic

ATAI Life Sciences ("ATAI" or the "Company"), a global biotechnology company developing psychedelic and non-psychedelic compounds for various mental...


Aug 24, 2020, 09:00 ET ATAI Life Sciences launches EmpathBio to treat post-traumatic stress disorder with novel MDMA product

Today, ATAI Life Sciences ("ATAI" or the "Company"), a global biotech developing psychedelic and non-psychedelic compounds for various mental health...


Aug 20, 2020, 09:30 ET ATAI and IntelGenx enter into Feasibility Agreement to develop pharmaceutical-grade polymeric film technologies for delivery of psychedelic medicines

Today, ATAI Life Sciences ("ATAI" or the "Company"), a global biotech developing psychedelic and non-psychedelic compounds for a variety of mental...


Jul 22, 2020, 10:00 ET ATAI launches Viridia Life Sciences to develop novel formulations of N, N-Dimethyltryptamine (DMT) for a range of mental health conditions

Today, ATAI Life Sciences ("ATAI" or the "Company"), a global biotech developing psychedelic and non-psychedelic compounds for a variety of mental...


Jul 22, 2020, 07:00 ET ATAI Life Sciences to Host Virtual R&D Day on July 29, 2020

ATAI Life Sciences AG, a global biotechnology company builder that envisions an end to mental illnesses, today announced that it will host a virtual...


Jul 09, 2020, 12:30 ET ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse

ATAI Life Sciences AG, a global biotechnology company builder that envisions an end to mental illnesses, has acquired a majority stake in New...


Jun 22, 2020, 10:00 ET ATAI launches IntroSpect Digital Therapeutics, appoints veteran software engineer David Keene as CEO

Today, ATAI Life Sciences ("ATAI" or the "Company"), a global biotech developing psychedelic and non-psychedelic compounds for various mental health...


Jan 24, 2020, 09:30 ET ATAI Life Sciences Announces Joint Venture with DemeRx to Develop Ibogaine For Opioid Use Disorder

ATAI Life Sciences AG ("ATAI" or the "Company"), a global biotech platform that envisions an end to mental illnesses, today announced an investment...


Jan 06, 2020, 09:00 ET ATAI Life Sciences Partners with Neuronasal Inc. to Develop Novel Treatment for mild Traumatic Brain Injury (mTBI)

ATAI Life Sciences AG ("ATAI" or the "Company"), a global biotech platform that envisions an end to mental illnesses, today announced that it has...


Sep 20, 2019, 09:00 ET GABA Therapeutics and ATAI Life Sciences Partner to Develop a Novel GABA Modulator for the Treatment of Mood Disorders

Today, GABA Therapeutics, a biotech company focused on the treatment of mood disorders, and ATAI Life Sciences, a global biotech company builder...